Do you want to read an article? Please log in or register.
Risk stratification using SpO2/FiO2 and PEEP at initial ARDS diagnosis and after 24 h in patients with moderate or severe ARDS
ARDS
Related content
RECOMMENDED
ARDS
Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial
JAMA.
Beitler JR, Sarge T, Banner-Goodspeed VM, Gong MN, Cook D, Novack V, Loring SH, Talmor D, EPVent-2 Study Group
doi: 10.1001/jama.
ARDS
PEEP Lower Than the ARDS Network Protocol is Associated with Higher Pediatric ARDS Mortality
Am J Respir Crit Care Med.
Khemani RG, Parvathaneni K, Yehya N, Bhalla AK, Thomas NJ, Newth CJL
doi: 10.1164/rccm.
Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis
Ann Am Thorac Soc.
Walkey AJ, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, Meade MO, Uleryk E, Hess D, Talmor DS, Thompson BT, Brower RG, Fan E
doi: 10.1513/AnnalsATS.201704-
ARDS
Differences between Patients in Whom Physicians Agree and Disagree about the Diagnosis of Acute Respiratory Distress Syndrome
Ann Am Thorac Soc.
Sjoding MW, Hofer TP, Co I, McSparron JI, Iwashyna TJ
doi: 10.1513/AnnalsATS.
Asthma
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
Lancet Respir Med.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zheng J, Gustafson P, Lamarca R, Puu M, Keen C, Alagappan VKT, Reddel HK
doi: 10.1016/S2213-2600(20)30416-1.
How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
Ann Intensive Care.
Hraiech S, Forel JM, Guervilly C, Rambaud R, Lehingue S, Adda M, Sylla P, Valera S, Carvelli J, Gainnier M, Papazian L, Bourenne J
doi: 10.1186/s13613-017-0305-2.
ARDS
Epidemiology, Mechanical Power, and 3-Year Outcomes in ARDS Patients Using Standardized Screening: An Observational Cohort Study
Ann Am Thorac Soc.
Parhar KKS, Zjadewicz K, Soo A, Sutton A, Zjadewicz M, Doig L, Lam C, Ferland A, Niven DJ, Fiest K, Stelfox HT, Doig CJ
doi: 10.1513/AnnalsATS.
RECOMMENDED
ARDS
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
JAMA.
Ranieri VM, Pettilä V, Karvonen MK, Jalkanen J, Nightingale P, Brealey D, Mancebo J, Ferrer R, Mercat A, Patroniti N, Quintel M, Vincent JL, Okkonen M, Meziani F, Bellani G, MacCallum N, Creteur J, Kluge S, Artigas-Raventos A, Maksimow M, Piippo I, Elima K, Jalkanen S, Jalkanen M, Bellingan G, INTEREST Study Group
doi: 10.1001/jama.2019.22525.
ARDS
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Lancet Respir Med.
Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ, Ortiz LA, Exline M, Christman JW, Abbott J, Delucchi KL, Caballero L, McMillan M, McKenna DH, Liu KD
doi: 10.1016/S2213-2600(18)30418-1.